When the phosphorylation of AKT was disturbed, the effect of CBX2 on glioma proliferation and chemoresistance was abolished, suggesting that CBX2 promotes glioma progression and chemoresistance through PTEN-controlled AKT activation. Here, CBX2 is linked to central nervous system cancer.